Pharmacist warned for injecting ‘homeopathic’ vitamin B12

The GPhC has issued a warning to a pharmacist who administered a B12 injection bought online to a colleague before receiving the injection herself.

The GPhC said the substance had been "sourced from the internet" (Shutterstock)

Bindy Rowcroft, registration number 2065942, was warned by the General Pharmaceutical Council (GPhC) for injecting a colleague with “homeopathic” vitamin B12 and letting the colleague inject her with the same substance.

In a hearing on November 19, the GPhC’s investigating committee heard that Rowcroft was “unsure as to the injected substance’s nature or provenance” because it had been “sourced from the internet”.

According to the determination document, the incident took place “on an unknown date between June and November 2024”, while Rowcroft was working as a pharmacist for The Medical Group.

Read more: Boots launches private vitamin B12 jab across 145 stores

The GPhC acknowledged the “reflection and insight” that Rowcroft has shown.

But it said that her actions breached a number of the standards for pharmacy professionals, including “professional judgement” and “leadership”.

“No appropriate checks”

The committee also heard that “no appropriate checks were made” about medical history, potential allergies or contraindications prior to giving the injections, and “no records of the injections were made”.

And the GPhC said that neither Rowcroft nor the colleague “were a registered patient at the practice” where she worked.

Read more: Pharmacy tech ‘voluntarily’ struck off after prison patient romance

The regulator warned Rowcroft that she “should only ever administer medication when she has fully satisfied herself that it is necessary, appropriate and safe to do so”.

It added that she “should also ensure she is aware of the nature and provenance of any such medication administered”.

Read more: Pharmacy tech struck off over £600k drug smuggling conviction

The committee concluded that a warning was the “appropriate outcome” in the case, and said that it would “remain on the public register for 12 months”.

Read the determination in full here.

Darcy Jimenez

Read more by Darcy Jimenez

Darcy became managing editor at C+D in April 2026, after joining as a senior reporter the previous August. She has been a journalist for several years, writing news and features across a range of areas, including healthcare and the pharmaceutical industry.

Latest from Regulation

More from News